← Back to Search

Procedure

Sofwave for Acne Scars

N/A
Waitlist Available
Research Sponsored by Sofwave Medical LTD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

Study Summary

This trial is exploring a new treatment for a disease by testing it on patients who agree to participate. The study is not randomized, meaning that patients are not assigned by chance to receive the new treatment or a placebo.

Eligible Conditions
  • Acne Scars

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of change of acne scars appearance, as assessed by independent masked evaluators at 3 months post last treatment session.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Acne ScarsExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sofwave
2020
Completed Phase 3
~240

Find a Location

Who is running the clinical trial?

Sofwave Medical LTDLead Sponsor
9 Previous Clinical Trials
512 Total Patients Enrolled

Media Library

Sofwave (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05358860 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the upper age limit for this study set at 30 years or higher?

"This trial has a lower age limit of 22 years old and an upper ceiling of 80, as stipulated by the study's inclusion criteria."

Answered by AI

Are there current vacancies for participants of this experiment?

"As per clinicaltrials.gov, this research is not presently enlisting patients; however, it was initially posted on February 1st 2022 and last updated November 20th 2022. Despite the fact that recruitment for this specific trial has concluded, there are still 121 other studies recruiting right now."

Answered by AI

Am I a viable candidate for this research endeavor?

"This clinical trial necessitates that participants are between 22 and 80 years old, with a diagnosis of acne. Around 60 people will be enrolled for the study."

Answered by AI

Who else is applying?

What state do they live in?
Connecticut
New Jersey
Other
New York
How old are they?
65+
18 - 65
What site did they apply to?
Other
SLSS, a Division of Schweiger Dermatology Group Research Office
Laser & Skin Surgery Center of New York®
UnionDerm
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
2
0
3+

Why did patients apply to this trial?

I have ance. I’ve tried microneedling alone, BBL and filler and have not gotten the results I would like. It’s hard to justify the cost of the treatments when only very minor improvements, if any, have occurred. A clinical trial would give me the opportunity to potentially see some improvement without the huge cost of additional treatments.
PatientReceived 1 prior treatment

How responsive is this trial?

Typically responds via
Email
Most responsive sites:
  1. SLSS, a Division of Schweiger Dermatology Group Research Office: < 48 hours
Average response time
  • < 2 Days
Recent research and studies
clinicaltrials.govStudy
Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement
2022. "Safety and Efficacy of Sofwave Treatment for Acne Scars Appearance Improvement". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05358860.
~19 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top